|
Volumn 41, Issue 6, 2009, Pages 2409-2411
|
Management of Chronic Kidney Disease After Renal Transplantation: Is It Different From Nontransplant Patients?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIANEMIC AGENT;
CALCIUM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEMOGLOBIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PARATHYROID HORMONE;
PHOSPHATE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CALCIUM BLOOD LEVEL;
CHOLESTEROL BLOOD LEVEL;
CHRONIC KIDNEY DISEASE;
CONTROLLED STUDY;
FEMALE;
FERRITIN BLOOD LEVEL;
GRAFT RECIPIENT;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MEAN ARTERIAL PRESSURE;
PARATHYROID HORMONE BLOOD LEVEL;
PHOSPHATE BLOOD LEVEL;
PREVALENCE;
PRIORITY JOURNAL;
SYSTOLIC BLOOD PRESSURE;
ADULT;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
CHOLESTEROL, LDL;
FEMALE;
FERRITINS;
FOLLOW-UP STUDIES;
GLOMERULAR FILTRATION RATE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERTENSION;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
EID: 68949212926
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2009.06.107 Document Type: Article |
Times cited : (8)
|
References (7)
|